ternational
stant
cisive
formative
[email protected]/ [email protected] ASIA EDITION
www.biopectrumasia.com
BioSpectum India Virtual
Digital Conference, Expo & Networking | September 2020
Strategy’s For Thriving In The Business
of Bio & Health Sciences New Normal
The only Indian event where Business & Commercial, Marketing Access, LifeScience, Biotech,
Pharma & Health Sciences...leaders build blueprint to set industry New Normal.
100+Industry 15+ Expert 10+ Trailblazing 5 Week On 1 Proven Virtual
Leaders Speakers Sessions Demand Platform.
Essential Themes
• Future Ready Leadership • Digital Transformation and Adaption
• Prepare for Results • Customer Engagement
India’s Leading Strategy Conference for Industry Executives
Life Science | Biotech | Pharma | Bio Services | Digital Healthcare | Medtech
Everything you can expect from a virtual conference …….and more
For More Information, Please Contact : Ankit Kankar (Project Manager)
[email protected] | +91 -9579069369
The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking here.
Firms racing to develop antibody treatment for COVID-19
The Coronavirus COVID-19 has raged the world and has infected 8,993,659 cases and killed 469,587 (as of
June 23, 2020. Source World Health Organization (WHO)). Pharma firms, scientists and governments all over
the world are racing to find a cure for the virus. The entire world is waiting for the vaccine; Moderna’s mRNA
vaccine will begin phase III study in July. Amidst all this, some biopharma companies are pushing to develop
antibody based treatments for the virus. Does that have any merit? Why are firms putting billions of dollars
into it when vaccines are the ultimate solution? Let’s find out.
Discover the best professional documents and content resources in AnyFlip Document Base.
Search